about
A new solution for a chronic problem; aqueous enteric coatingComparison of various cosolvency models for calculating solute solubility in water-cosolvent mixtures.Comparison of the Analgesic Effect of Diclofenac Sodium-Eudragit(®) RS100 Solid Dispersion and Nanoparticles Using Formalin Test in the Rats.Antimicrobial activity of the metals and metal oxide nanoparticles.Calcium carbonate nanoparticles as cancer drug delivery system.Methylprednisolone acetate-loaded hydroxyapatite nanoparticles as a potential drug delivery system for treatment of rheumatoid arthritis: In vitro and in vivo evaluations.Development and characterization of a novel lipohydrogel nanocarrier: repaglinide as a lipophilic model drug.Physicochemical characterization and in vivo evaluation of triamcinolone acetonide-loaded hydroxyapatite nanocomposites for treatment of rheumatoid arthritis.Hydrogel nanoparticles and nanocomposites for nasal drug/vaccine delivery.Development of amitriptyline buccoadhesive tablets for management of pain in dental procedures.Comparison of Different Nanosuspensions as Potential Ophthalmic Delivery Systems for Ketotifen Fumarate.Development of a nanoprecipitation method for the entrapment of a very water soluble drug into Eudragit RL nanoparticles.Design and evaluation of 1- and 3-layer matrices of verapamil hydrochloride for sustaining its release.Development and characterization of solid dispersion of piroxicam for improvement of dissolution rate using hydrophilic carriers.Studies on dissolution enhancement of prednisolone, a poorly water-soluble drug by solid dispersion techniqueDevelopment of azithromycin-PLGA nanoparticles: physicochemical characterization and antibacterial effect against Salmonella typhi.Evaluation of drug release kinetics and physico-chemical characteristics of metronidazole floating beads based on calcium silicate and gas-forming agents.Solubility prediction for furosemide in water-cosolvent mixtures using the minimum number of experiments.The effect of surfactants on the skin penetration of diazepam.Inclusion of piroxicam in mesoporous phosphate glass-ceramic and evaluation of the physiochemical characteristics.Enhancement of dissolution rate and anti-inflammatory effects of piroxicam using solvent deposition technique.Prediction of benzodiazepines solubility using different cosolvency models.Effect of solvent type on retardation properties of diltiazem HCl form liquisolid tablets.The enhancement effect of surfactants on the penetration of lorazepam through rat skin.Physicochemical and anti-bacterial performance characterization of clarithromycin nanoparticles as colloidal drug delivery system.Preparation and evaluation of sustained release calcium alginate beads and matrix tablets of acetazolamide.Methylprednisolone acetate-Eudragit® RS100 electrospuns: Preparation and physicochemical characterization.Enhancement of dissolution rate of piroxicam using liquisolid compacts.Simultaneous determination of naproxen, ketoprofen and phenol red in samples from rat intestinal permeability studies: HPLC method development and validation.Improved compaction and packing properties of naproxen agglomerated crystals obtained by spherical crystallization technique.Propranolol hydrochloride osmotic capsule with controlled onset of release.Inhibition of endotoxin-induced uveitis by methylprednisolone acetate nanosuspension in rabbits.Quantitative structure-pharmacokinetic relationship modelling: apparent volume of distribution.Morphological and physicochemical evaluation of the propranolol HCl-Eudragit® RS100 electrosprayed nanoformulations.Application of Box-Behnken design to prepare gentamicin-loaded calcium carbonate nanoparticles.Relationship between potency and boiling point of general anesthetics: a thermodynamic consideration.QSPR models for the prediction of apparent volume of distribution.A model to represent solvent effects on the chemical stability of solutes in mixed solvent systems.Physicochemical characterization of atorvastatin calcium/ezetimibe amorphous nano-solid dispersions prepared by electrospraying method.Ciprofloxacin HCl-loaded calcium carbonate nanoparticles: preparation, solid state characterization, and evaluation of antimicrobial effect against Staphylococcus aureus.
P50
Q28199965-0E41AD0E-B94E-4C71-9424-FF299530382CQ33595356-C7345B16-4785-4020-BB5C-B578AF4A746CQ35155314-C2528886-8239-4FCF-ABA2-18C49E5CA4B6Q38256523-765C7F49-06A0-46FE-AA55-5C852F20FECFQ38500958-652647F4-4FBE-4536-AA17-A968BECD9ECBQ38770287-0CA01578-56AC-415B-A23A-BC6EB916D640Q38775340-CB115484-AE7B-42B3-BE66-8799C83E7908Q38803862-686B7EB3-132B-48D8-8B8C-8B80F05313A1Q38879581-63913A16-FACD-4707-A9DE-340352D16ECBQ39273162-E2A736DE-8C01-4821-A621-26951D25BB7FQ41513479-2B7DDA1F-F613-496A-84D6-719823E4B974Q41859836-91D8FEB3-BCE1-472F-940A-B8BF3E5D8F2EQ41990204-6CBB932A-FC8A-4D72-B208-FB2524A40B21Q42024752-60E28295-2AEF-4B73-A529-574B4DF819C4Q42102623-D630C733-05F7-4EA2-A06B-2DF7729496B9Q43014538-8EC3D82A-AF21-41F6-8AFE-5F50C05C540AQ43289088-0F0C14EC-1C43-45D3-B1F6-4691B43AC9A9Q43731660-5294F86B-3F07-44AA-B2D8-BADBDB82CD2CQ43750683-60488215-90B5-473A-BBB3-7A10A3208FF0Q44030055-D78036E9-7B14-4B1D-9938-DDB02A012BBFQ44084008-6F3F6C55-1855-4211-A06C-3B798D0F6E59Q44091117-040DACB3-6E9C-4D36-814C-7D7DC0C27F32Q44276977-02F1F1B1-DA53-4A8E-AF5E-9214427E8073Q44277715-D7264A5A-7041-443B-8BD3-53A14ECB0301Q44364824-409E2931-72F3-4D9D-B840-C58BA51E3819Q44849266-2400B54E-433A-4DAA-8E75-75D4AC690CD9Q45754039-555F267F-C3F1-41BE-ACEC-DA2DD09AA30DQ46452274-82575F1D-85C0-435E-B2EE-F443BAE5E89BQ46495440-91C4C7E8-3A21-4419-8BA9-BF72664ADF6DQ46867077-4FEB09DC-EC2A-43A8-B58F-E7E53F7BA2C4Q46906660-5174C588-5746-4010-B12C-6486B2ECC2AAQ46978247-5E3D1F84-C0C2-4B89-A47A-E46DA4EB00FFQ47939712-66C85BB2-D49C-4DB7-924A-C48621B97A6FQ48014962-8D590E0E-80B8-4052-9A99-C2DE7B82947AQ50919035-36EE1045-8A02-4A27-9568-3FFB608217FDQ51389663-18B9C0A4-EF5C-46E8-A95D-044B147CDA75Q51941789-33DE31E1-63A5-4175-9EA2-C47DE5262BDAQ52034685-08AAB02D-3D0B-44B1-889A-7A9BAED59CFCQ53067118-C995D542-FF52-4FC2-9F78-C7654E9636F8Q53137843-CD7C6882-EBE9-477E-8620-96F49100AAEB
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mohammad Barzegar-Jalali
@ast
Mohammad Barzegar-Jalali
@en
Mohammad Barzegar-Jalali
@es
Mohammad Barzegar-Jalali
@nl
Mohammad Barzegar-Jalali
@sl
type
label
Mohammad Barzegar-Jalali
@ast
Mohammad Barzegar-Jalali
@en
Mohammad Barzegar-Jalali
@es
Mohammad Barzegar-Jalali
@nl
Mohammad Barzegar-Jalali
@sl
prefLabel
Mohammad Barzegar-Jalali
@ast
Mohammad Barzegar-Jalali
@en
Mohammad Barzegar-Jalali
@es
Mohammad Barzegar-Jalali
@nl
Mohammad Barzegar-Jalali
@sl
P106
P1153
7004260785
P21
P31
P496
0000-0001-6340-7586